F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in F-star Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −3 vs. Q4 2021
- Shares held
- 8.18M
- −2.42M (−22.9%) vs. Q4 2021
- Total value
- $29.0M
- −$24.2M (−45.5%) vs. Q4 2021
- New holders
- 7
- 9 more added
- Sold out
- 10
- 11 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 59 | $57.8M |
| Q3 2022 | 54 | $35.5M |
| Q2 2022 | 53 | $45.1M |
| Q1 2022 | 40 | $29.0M |
| Q4 2021 | 43 | $53.2M |
| Q3 2021 | 37 | $71.9M |
| Q2 2021 | 41 | $93.5M |
| Q1 2021 | 26 | $19.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding F-star Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | 66 | $0 | 0.00% | −5,796−98.9% | Reduced |
| Wells Fargo & Company | 117 | $0 | 0.00% | +1+0.9% | Added |
| UBS Group AG | 50 | $0 | 0.00% | −189−79.1% | Reduced |
| TCI Wealth Advisors, Inc. | 300 | $1.00K | 0.00% | +100+50.0% | Added |
| Bank of America Corp | 162 | $1.00K | 0.00% | +162 | New |
| Tower Research Capital LLC (TRC) | 3,065 | $11.0K | 0.00% | −7,680−71.5% | Reduced |
| Advisor Group Holdings, Inc. | 4,327 | $15.0K | 0.00% | +3,278+312.5% | Added |
| Bryn Mawr Trust Co | 10,000 | $36.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 10,456 | $37.0K | 0.00% | +10,456 | New |
| Jump Financial, LLC | 11,300 | $40.0K | 0.00% | −13,100−53.7% | Reduced |
| Silvercrest Asset Management Group LLC | 12,585 | $45.0K | 0.00% | 00.0% | Unchanged |
| Private Capital Advisors, Inc. | 13,083 | $46.0K | 0.01% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 13,564 | $48.0K | 0.00% | +13,564 | New |
| D. E. Shaw & Co., Inc. | 15,865 | $56.0K | 0.00% | +15,865 | New |
| Morgan Stanley | 18,041 | $64.0K | 0.00% | −808−4.3% | Reduced |
| Parsons Capital Management Inc | 21,291 | $76.0K | 0.01% | −588−2.7% | Reduced |
| JPMorgan Chase & Co | 21,335 | $76.0K | 0.00% | +12,891+152.7% | Added |
| Goldman Sachs Group Inc | 33,802 | $120.0K | 0.00% | +33,802 | New |
| Northern Trust Corp | 35,102 | $125.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 45,752 | $163.0K | 0.00% | 00.0% | Unchanged |
| Connolly Sarah T. | 53,001 | $188.0K | 0.11% | 00.0% | Unchanged |
| State Street Corp | 53,150 | $189.0K | 0.00% | +7,180+15.6% | Added |
| Manufacturers Life Insurance Company, The | 54,981 | $194.4K | 0.00% | +54,981 | New |
| TD Asset Management Inc | 58,487 | $208.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 75,190 | $267.0K | 0.00% | +75,190 | New |
| Millennium Management LLC | 85,834 | $305.0K | 0.00% | +40,514+89.4% | Added |
| Geode Capital Management, LLC | 145,431 | $516.0K | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 185,261 | $658.0K | 0.09% | −124,442−40.2% | Reduced |
| Renaissance Technologies LLC | 249,140 | $884.0K | 0.00% | −40,271−13.9% | Reduced |
| Citadel Advisors LLC | 292,993 | $1.04M | 0.00% | +18,893+6.9% | Added |
| BlackRock Inc. | 295,947 | $1.05M | 0.00% | +4,776+1.6% | Added |
| Atlas Venture Advisors, Inc. | 574,996 | $2.04M | 0.44% | 00.0% | Unchanged |
| Vanguard Group Inc | 598,437 | $2.12M | 0.00% | −149,263−20.0% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $2.13M | 0.27% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 601,394 | $2.13M | 0.00% | +356,317+145.4% | Added |
| DAFNA Capital Management LLC | 693,785 | $2.46M | 0.64% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 751,889 | $2.67M | 0.07% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 789,590 | $2.80M | 0.00% | −68,505−8.0% | Reduced |
| Point72 Asset Management, L.P. | 850,000 | $3.02M | 0.01% | −131,249−13.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 900,000 | $3.19M | 0.01% | 00.0% | Unchanged |
| Ridgeback Capital Investments L.P. | 0 | $0 | 0.00% | −1,834,360−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −522,158−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −79,092−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −49,933−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,251−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,700−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,854−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Arcadia Investment Management Corp | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,366−100.0% | Sold out |